| scholarly article | Q13442814 |
| P2093 | author name string | Carsten Nieder | |
| Jan Norum | |||
| Astrid Dalhaug | |||
| Kirsten Marienhagen | |||
| P2860 | cites work | A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases | Q81128526 |
| Can current prognostic scores reliably guide treatment decisions in patients with brain metastases from malignant melanoma? | Q84047594 | ||
| Radiosurgery for treatment of brain metastases: estimation of patient eligibility using three stratification systems. | Q30838985 | ||
| Radiosurgery for brain metastases: a score index for predicting prognosis | Q30848072 | ||
| Identification of prognostic factors in patients with brain metastases: a review of 1292 patients | Q33177750 | ||
| A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. | Q33302366 | ||
| Prognostic indices for brain metastases--usefulness and challenges | Q33414874 | ||
| Determinants of survival in patients with brain metastases from cutaneous melanoma | Q33794890 | ||
| Lactate: mirror and motor of tumor malignancy | Q35837050 | ||
| Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials | Q36857456 | ||
| Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma | Q43995413 | ||
| Survival prediction in terminally ill cancer patients by clinical estimates, laboratory tests, and self-rated anxiety and depression | Q48090050 | ||
| Radiation therapy for brain metastases from lung carcinoma. Prospective randomized trial according to the level of lactate dehydrogenase | Q48161661 | ||
| Prognostic factors in patients with brain metastases from lung carcinoma | Q48371872 | ||
| Prediction of short survival in patients with brain metastases based on three different scores: a role for 'triple-negative' status? | Q48456572 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 609323 | |
| P577 | publication date | 2012-04-19 | |
| P1433 | published in | The Scientific World Journal | Q7762585 |
| P1476 | title | Towards improved prognostic scores predicting survival in patients with brain metastases: a pilot study of serum lactate dehydrogenase levels. | |
| P478 | volume | 2012 |
| Q54367194 | Impact of systemic treatment on survival after whole brain radiotherapy in patients with brain metastases. |
| Q35672391 | KPS/LDH index: a simple tool for identifying patients with metastatic melanoma who are unlikely to benefit from palliative whole brain radiotherapy. |
| Q48001323 | Predicting prognosis of short survival time after palliative whole-brain radiotherapy |
| Q35984979 | Prognostic significance of serum LDH in small cell lung cancer: A systematic review with meta-analysis |
| Q48171393 | Radiotherapy versus best supportive care in patients with brain metastases and adverse prognostic factors |
| Q90700727 | Serum lactate dehydrogenase predicts survival in small-cell lung cancer patients with brain metastases that were treated with whole-brain radiotherapy |
| Q33619046 | Tetravalent antibody-scTRAIL fusion proteins with improved properties |
| Q38565718 | The Regulation and Function of Lactate Dehydrogenase A: Therapeutic Potential in Brain Tumor |
| Q47133539 | The prognostic value of the serum neuron specific enolase and lactate dehydrogenase in small cell lung cancer patients receiving first-line platinum-based chemotherapy |
Search more.